Click Here to return To Results

 

Alemtuzumab for Multiples Sclerosis: Who and When to treat? Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012 See this aricle in Pubmed Article Abstract No abstract available for this article

Related Tags

(click to filter results - removes previous filter) adverse drug reaction alemtuzumab autoimmune disease bradykinesia complications efficacy herpes virus infection infection interferon beta 1-a MRI,abnormal MRI,lesion burden multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,treatment of safety thrombocytopenia treatment of neurologic disorder urinary tract infection

Click Here to return To Results